Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-16-140709

Options or other derivatives

  • Chief Financial Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
NIFFENEGGER KATHI Chief Financial Officer 2016-12-20 Grant or award · Share Option (Right to Buy) +10,000 10,000 D: show line 1 in the form
Loading xslF345X03/v455475_4.xml…